Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 6.67% vs -64.04% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 18.27% vs -797.26% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 18.91% vs -80.66% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is 8.00% vs -50.98% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Nektar Therapeutics With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 6.67% vs -64.04% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -52.34% vs 14.63% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 18.27% vs -797.26% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 20.61% vs -2.54% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 18.91% vs -80.66% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -1.71% vs -9.72% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 8.00% vs -50.98% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -15.62% vs 3.23% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






